In November 2025, Abbott agreed to acquire Exact Sciences for approximately $21 billion. Madison, Wisconsin–based Exact ...

Stereotaxis (NYSE:STXS) today reported its fourth-quarter and full-year financial results ahead of expected growth in 2026.

Verily will integrate data from Samsung’s Galaxy Watch, enabling research sponsors to run real-world studies with re-contactable participants.

BTIG analysts continue to expect growth from Dexcom (Nasdaq:DXCM) after meeting with the company's senior investor relations (IR) officials.

View streamlines imaging analysis and visualization by using a suite of AI-enabled tools intended to aid clinical decision making.

ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.

SS Innovations (Nasdaq:SSII) announced today that it completed a private placement of common stock worth $18.6 million.

Stryker (NYSE: SYK) announced today that it launched its new SmartHospital platform aimed at transforming care delivery.

Pulse Biosciences (Nasdaq:PLSE) today announced clinical findings demonstrating the durability of its nPulse Vybrance system.

Olympus announced today that it appointed Denise Lane to the role of chief officer of inclusion (COI), effective April 1, ...

The SmartHeart AI-powered MR workflow. [Image courtesy of Philips] Philips (NYSE: PHG) + announced today that it received FDA 510(k) clearance for its SmartHeart planning solution. SmartHeart, an ...

Medtronic has been making significant strides in its Cranial & Spinal Technologies (CST) business unit recently.